4SC AG: Conference call to be hosted on 29 March 2017 to present annual results 2016

Planegg-Martinsried, Germany, 22 March 2017 – 4SC AG (4SC, FSE Prime Standard: VSC) will announce financial results 2016 for the Group and publish the Company’s Annual Report 2016 on 29 March 2017. On this day, the Management of 4SC will host a conference call at 3 p.m. CEDT (9 a.m. EDT) to inform about the consolidated financial statements and important developments in the reporting period and beyond.

Investors, financial analysts, and journalists interested in participating in the conference call can access via the following telephone numbers:

A presentation document supporting the conference call will be available on 29 March 2017, at 4SC’s website. After the event, a replay can be accessed from there as well.

Further information

About 4SC

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs through epigenetic mechanisms. Such drugs are intended to provide patients with innovative treatment options that are more tolerable and efficacious than existing therapies and provide a better quality of life.

4SC’s pipeline is protected by a comprehensive portfolio of patents and comprises promising products that are in various stages of preclinical and clinical development. 4SC’s aim is to generate future growth and enhance its enterprise value by entering into partnerships with pharmaceutical and biotech companies. Founded in 1997, 4SC had 49 employees as of 31 December 2016. 4SC has been listed on the Prime Standard of the Frankfurt Stock Exchange since December 2005.

Forward-looking information

Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of 4SC as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond 4SC’s control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. 4SC expressly disclaims any obligation or undertaking to release any updates or revisions to any such statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.

The Ruth Group
Robert Flamm, Ph.D., email hidden; JavaScript is required, +1 646-536-7017

MC Services
Katja Arnold, email hidden; JavaScript is required, +49 89 210228-40